These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinicopathological features of pancreatic intraepithelial neoplasias and their relationship to intraductal papillary-mucinous tumors. Takaori K; Kobashi Y; Matsusue S; Matsui K; Yamamoto T J Hepatobiliary Pancreat Surg; 2003; 10(2):125-36. PubMed ID: 14505145 [TBL] [Abstract][Full Text] [Related]
3. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Adsay NV; Merati K; Andea A; Sarkar F; Hruban RH; Wilentz RE; Goggins M; Iocobuzio-Donahue C; Longnecker DS; Klimstra DS Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756 [TBL] [Abstract][Full Text] [Related]
4. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma. Zhang L; Sanderson SO; Lloyd RV; Smyrk TC Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542 [TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of MUC3 and MUC4 membrane-associated mucins and sialyl Le(x) antigen in pancreatic intraepithelial neoplasia. Park HU; Kim JW; Kim GE; Bae HI; Crawley SC; Yang SC; Gum JR; Batra SK; Rousseau K; Swallow DM; Sleisenger MH; Kim YS Pancreas; 2003 Apr; 26(3):e48-54. PubMed ID: 12657964 [TBL] [Abstract][Full Text] [Related]
6. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Wilentz RE; Iacobuzio-Donahue CA; Argani P; McCarthy DM; Parsons JL; Yeo CJ; Kern SE; Hruban RH Cancer Res; 2000 Apr; 60(7):2002-6. PubMed ID: 10766191 [TBL] [Abstract][Full Text] [Related]
7. PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma. Gold DV; Karanjawala Z; Modrak DE; Goldenberg DM; Hruban RH Clin Cancer Res; 2007 Dec; 13(24):7380-7. PubMed ID: 18094420 [TBL] [Abstract][Full Text] [Related]
8. Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): additional evidence for a recently proposed model of progression. Klein WM; Hruban RH; Klein-Szanto AJ; Wilentz RE Mod Pathol; 2002 Apr; 15(4):441-7. PubMed ID: 11950919 [TBL] [Abstract][Full Text] [Related]
9. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Maitra A; Adsay NV; Argani P; Iacobuzio-Donahue C; De Marzo A; Cameron JL; Yeo CJ; Hruban RH Mod Pathol; 2003 Sep; 16(9):902-12. PubMed ID: 13679454 [TBL] [Abstract][Full Text] [Related]
10. Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN). Karamitopoulou E; Zlobec I; Tornillo L; Carafa V; Schaffner T; Brunner T; Borner M; Diamantis I; Zimmermann A; Terracciano L Pathology; 2010 Apr; 42(3):229-34. PubMed ID: 20350215 [TBL] [Abstract][Full Text] [Related]
11. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects. Adsay NV; Basturk O; Cheng JD; Andea AA Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479 [TBL] [Abstract][Full Text] [Related]
13. Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia. Lee KM; Cao D; Itami A; Pour PM; Hruban RH; Maitra A; Ouellette MM Histopathology; 2007 Oct; 51(4):539-46. PubMed ID: 17714470 [TBL] [Abstract][Full Text] [Related]
14. Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components. Sanada Y; Yoshida K; Ohara M; Oeda M; Konishi K; Tsutani Y Pancreas; 2006 Mar; 32(2):164-70. PubMed ID: 16552336 [TBL] [Abstract][Full Text] [Related]
15. Comparison of histologic subtype and growth pattern in intraductal papillary-mucinous carcinoma of the pancreas. Sanada Y; Kunita S; Yoshida K Oncol Rep; 2008 Jun; 19(6):1435-43. PubMed ID: 18497948 [TBL] [Abstract][Full Text] [Related]
16. Amplification and overexpression of HER-2/neu in invasive ductal carcinomas of the pancreas and pancreatic intraepithelial neoplasms and the relationship to the expression of p21(WAF1/CIP1). Hermanová M; Lukás Z; Nenutil R; Brázdil J; Kroupová I; Kren L; Pazourková M; Růzicka M; Díte P Neoplasma; 2004; 51(2):77-83. PubMed ID: 15190415 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47. Maitra A; Iacobuzio-Donahue C; Rahman A; Sohn TA; Argani P; Meyer R; Yeo CJ; Cameron JL; Goggins M; Kern SE; Ashfaq R; Hruban RH; Wilentz RE Am J Clin Pathol; 2002 Jul; 118(1):52-9. PubMed ID: 12109856 [TBL] [Abstract][Full Text] [Related]
18. Where and when does pancreatic carcinoma start? Lüttges J; Hahn S; Klöppel G Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289 [TBL] [Abstract][Full Text] [Related]
19. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Andrianifahanana M; Moniaux N; Schmied BM; Ringel J; Friess H; Hollingsworth MA; Büchler MW; Aubert JP; Batra SK Clin Cancer Res; 2001 Dec; 7(12):4033-40. PubMed ID: 11751498 [TBL] [Abstract][Full Text] [Related]
20. Different patterns of p16INK4A and p53 protein expressions in intraductal papillary-mucinous neoplasms and pancreatic intraepithelial neoplasia. Abe K; Suda K; Arakawa A; Yamasaki S; Sonoue H; Mitani K; Nobukawa B Pancreas; 2007 Jan; 34(1):85-91. PubMed ID: 17198188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]